2024 annual financial data
Agios Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,068.12%.
Operating income was -425,737,000 USD and net income was 673,725,000 USD.
Operating cash flow was -389,841,000 USD.
Get free Agios Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,498,000 USD
- Operating income
- -425,737,000 USD
- Net income
- 673,725,000 USD
- Operating cash flow
- -389,841,000 USD